Lake Country Urology PLLC

Lake Country Urology PLLC was paid $1.10M by Medicaid between Sep 2020 and Jul 2022, across 9 billing codes. Its largest line is M0244, Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency — 57% of everything it billed.

Compared with peers

Next to other Urology Physician providers in New York

Rank by total paid#15 of 461

Median peer was paid$6K

This provider vs. median191×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	25	$163.28
2021	2,512	$901K
2022	310	$199K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
M0244	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	57%	733	716	$630K
M0248	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	16%	227	225	$172K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	1,542	1,536	$141K
M0223	Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	6.5%	101	101	$71K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	2.6%	80	80	$28K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	2.5%	88	88	$27K
M0246	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency	2.2%	28	28	$25K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	23	23	$5K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	25	25	$163.28

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMADEB, RALPH (PHYSICIAN)